
Qynapse part of the “Top 100 start-ups where to invest”
Qynapse was featured in the 2018 selection of the “Top 100 start-ups where to invest”
in the French business magazine Challenges
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
Qynapse (Paris)
130, rue de Lourmel
75015 Paris – France
contact[@]qynapse.com
This website uses cookies. By continuing to browse our website, you are agreeing to our use of cookies.
For more information, see our privacy policy